Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases

Li C., Ni YQ., Xu H., Xiang QY., Zhao Y., Zhan JK.

Narrative Review on Neuroinflammation, Autoimmune Research, published in Signal Transduct Target Ther (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Signal Transduct Target Ther (2021)
Reported sample size
—
Source database
Europe PMC
PMID
34753929
PMCID
PMC8578673
DOI
10.1038/s41392-021-00779-x
Citations
325

Abstract (original English)

Exosomes play a role as mediators of cell-to-cell communication, thus exhibiting pleiotropic activities to homeostasis regulation. Exosomal non-coding RNAs (ncRNAs), mainly microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are closely related to a variety of biological and functional aspects of human health. When the exosomal ncRNAs undergo tissue-specific changes due to diverse internal or external disorders, they can cause tissue dysfunction, aging, and diseases. In this review, we comprehensively discuss the underlying regulatory mechanisms of exosomes in human diseases. In addition, we explore the current knowledge on the roles of exosomal miRNAs, lncRNAs, and circRNAs in human health and diseases, including cancers, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and infectious diseases, to determine their potential implication in biomarker identification and therapeutic exploration.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansCommunicable DiseasesNeoplasmsNeurodegenerative DiseasesCardiovascular DiseasesMetabolic DiseasesAutoimmune DiseasesMicroRNAsExosomesRNA, Long Noncoding

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research